1H3 — Clearbridge Health Balance Sheet
0.000.00%
- SG$8.59m
- SG$9.65m
- SG$9.90m
- 31
- 46
- 15
- 17
Annual balance sheet for Clearbridge Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14 | 14.6 | 6.05 | 4.48 | 4.29 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9.26 | 8.25 | 3.43 | 2.84 | 3.18 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 30.8 | 31.1 | 10.8 | 8.51 | 7.99 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.89 | 6.47 | 2.1 | 3.27 | 2.07 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 97 | 82.7 | 58.2 | 23.9 | 21.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19.6 | 17.2 | 5.1 | 4.91 | 9.19 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 36.5 | 30.5 | 16.8 | 13.7 | 12 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 60.5 | 52.2 | 41.4 | 10.2 | 9.21 |
| Total Liabilities & Shareholders' Equity | 97 | 82.7 | 58.2 | 23.9 | 21.2 |
| Total Common Shares Outstanding |